未登录

B

Bhavin Vyas

uka tarsadia university

H指数:23

被引数:1,919

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fasting as a Multisystem Health Modulator: A Narrative Review of Metabolic, Cardiovascular, Immune, Neurocognitive, and Psychospiritual Effects

禁食作为多系统健康调节剂：代谢、心血管、免疫、神经认知和心理精神效应的叙事性综述

Current Nutrition Reports

IF5.5

2026-01-070

PRE

Folate-Functionalized Polymeric Nanoparticles for 5-Fluorouracil Delivery to Prostate Cancer: Physicochemical and In Vitro/In Vivo Characterization

IF4.3

2025-12-010

PRE

In Silico Guided Design of TPGS-Derived Polymeric Micelles for Improved Solubility and Antiplatelet Efficacy of Ticagrelor

基于计算机指导的TPGS衍生聚合物胶束设计，以改善替格瑞洛的溶解度和抗血小板效果

IF3.2

2025-10-200

OA

Impact of Clinical Pharmacist-Led Discharge Counseling on Health Outcomes and Quality of Life in Chronic Disease Patients

临床药师主导的出院指导对慢性病患者健康结局和生活质量的影响

JOURNAL OF YOUNG PHARMACISTS

IF0

2025-10-010

OAAI

Self-assembled Zanubrutinib-loaded lipid polymer hybrid nanoparticles for enhanced oral absorption by lymphatic uptake: in vitro, ex vivo and in vivo evaluations

自组装载泽鲁布替尼的脂质聚合物杂化纳米粒通过淋巴摄取增强口服吸收：体外、离体及体内评价

Pharmaceutical Development and Technology

IF2.5

2025-09-290

PRE

Recent advancements in 2D MXenes-based theranostic nanoplatforms for breast cancer treatment

JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY

IF6

2025-05-010

PRE

Integration of Synchronizing In Silico, In Vitro, and In Vivo Strategies for the Development of Antipsoriatic Apremilast-loaded Nanostructured Lipid Carrier Embedded in Hydrogel

AAPS PHARMSCITECH

IF4

2025-04-250

PRE

Hyaluronic Acid Conjugated Liposomes for Targeted Delivery of Ibrutinib: In Vitro, Cell Line, and In Vivo Assessment

IF3.2

2025-02-180

PRE

Investigation of Mirabegron-loaded Nanostructured Lipid Carriers for Improved Bioabsorption: Formulation, Statistical Optimization, and In-Vivo Evaluation

AAPS PHARMSCITECH

IF4

2024-09-250

PRE

Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2024-08-051

PRE

Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo , and in vivo studies

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2024-05-011

OAAI

Design, Development, and Evaluation of SA-F127:TPGS Polymeric Mixed Micelles for Improved Delivery of Glipizide Drug: In-vitro, Ex-vivo, and In-vivo Investigations

AAPS PHARMSCITECH

IF4

2023-10-172

PRE

Quality-by-Design-Based Development of Rivaroxaban-Loaded Liquisolid Compact Tablets with Improved Biopharmaceutical Attributes

AAPS PHARMSCITECH

IF4

2023-08-285

PRE

Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake

AAPS PHARMSCITECH

IF4

2023-06-235

PRE

Effect of co-administration of metformin and extracts of Costus pictus D.Don leaves on alloxan-induced diabetes in rats

JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE

IF3

2022-05-0115

OAAI

Amalgamation of solid dispersion and melt adsorption techniques for augmentation of oral bioavailability of novel anticoagulant rivaroxaban

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2022-04-255

PRE

Amalgamation of Solid Dispersion and Melt Adsorption Technique: Improved In Vitro and In Vivo Performance of Ticagrelor Tablets

AAPS PHARMSCITECH

IF4

2021-10-217

PRE

Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization

AAPS PHARMSCITECH

IF4

2021-08-1220

PRE

Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-05-0130

PREAI

Impact of a clinical pharmacist with oncology specialty training on clinical, humanistic and economic outcomes in an oncology setup

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI